Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy

Valentin Burkart1, Kathrin Kowalski1, David Aldag-Niebling1

  • 1Institute for Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.

Insights

Transcriptional bursting in sarcomeric genes causes cellular protein and mRNA variations in hypertrophic cardiomyopathy (HCM) patients. This allelic mosaicism contributes to contractile imbalance and disease development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Cellular Physiology

Background:

  • Transcriptional bursting is a prevalent gene expression mechanism.
  • Allelic expression variability arises from independent transcription of gene alleles.
  • Hypertrophic Cardiomyopathy (HCM) is linked to mutations in sarcomeric proteins.

Purpose of the Study:

  • Investigate burst-like transcription of sarcomeric genes (MYBPC3, TNNI3) in HCM.
  • Determine the consequences of this transcription mode on allelic mRNA and protein distribution.
  • Correlate transcriptional bursting with cardiac contractile function in HCM patients.

Main Methods:

  • Fluorescence in situ hybridization (RNA-FISH) to visualize gene transcription.
  • Analysis of allelic mRNA ratios in single cardiomyocytes.
  • Assessment of wildtype cMyBP-C protein distribution in cardiac tissue.
  • Measurement of calcium-dependent force generation in cardiomyocytes.

Main Results:

  • MYBPC3 and TNNI3 genes exhibit burst-like transcription in HCM patient cardiac tissue.
  • Unequal allelic ratios of TNNI3 mRNA and variable wildtype cMyBP-C protein distribution were observed.
  • Mutations caused opposing changes in calcium sensitivity, but all patients showed variable contractile force.
  • Significant contractile imbalance was evident among individual cardiomyocytes.

Conclusions:

  • Burst-like transcription of sarcomeric genes creates an allelic mosaic at mRNA and protein levels in neighboring cardiomyocytes.
  • This mosaicism is a likely contributor to the contractile imbalance observed in HCM.
  • Transcriptional bursting and subsequent allelic mosaicism are implicated in the pathogenesis of HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
42
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
13.9K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
22
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31